Trial Profile
Prospective, Randomized, Double-blind Study, Parallel-group, Multi-center Trial Assessing the Effects of Escalating Doses of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolepsy.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Pitolisant (Primary) ; Modafinil
- Indications Narcolepsy
- Focus Therapeutic Use
- Acronyms Harmony II; Harmony2
- 08 Feb 2013 Status changed from discontinued to completed as reported by ClinicalTrials.gov.
- 08 Jun 2012 Actual patient number is 14 according to ClinicalTrials.gov.
- 20 Feb 2010 New trial record